Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer

Abstract Objective To assess the factors associated with the use of active surveillance (AS) in NCCN favourable intermediate‐risk (FIR) prostate cancer (PCa) patients who received the 17‐gene Genomic Prostate Score (GPS) assay. Material and Methods Contemporary data were collected from academic and...

Full description

Bibliographic Details
Published in:	BJUI Compass
Main Authors:	Eric Margolis, Benjamin H. Lowentritt, Christopher M. Pieczonka, John P. Bennett, Marina Pavlova, Joao Paulo Zambon, Jack Groskopf, Edward Uchio
Format:	Article
Language:	English
Published:	Wiley 2025-03-01
Subjects:	active surveillance biomarkers Favourable intermediate‐risk genomic testing prostate cancer
Online Access:	https://doi.org/10.1002/bco2.494

Similar Items

PSMA PET in Favourable Intermediate-Risk Prostate Cancer? Gold Mine or Money Pit
by: Weiwei Shi, et al.
Published: (2025-08-01)

Prospective Implementation and Early Outcomes of a Risk-stratified Prostate Cancer Active Surveillance Follow-up Protocol
by: Vineetha Thankapannair, et al.
Published: (2023-03-01)

Cone Beam Computed Tomography Radiomics for Prostate Cancer: Favourable vs. Unfavourable Prognosis Prediction
by: Bruno Mendes, et al.
Published: (2023-01-01)

A modeling study to estimate prostate cancer‐specific mortality on active surveillance for men with favorable intermediate‐risk prostate cancer: Results from the SEARCH cohort
by: Paige K. Kuhlmann, et al.
Published: (2023-05-01)

Prognostic Value of the Intermediate-risk Feature in Men with Favorable Intermediate-risk Prostate Cancer: Implications for Active Surveillance
by: Michael V. Sherer, et al.
Published: (2023-04-01)

Influence of Active Surveillance on Gleason Score Upgrade and Prognosis in Low- and Favorable Intermediate-Risk Prostate Cancer
by: Xuanhan Hu, et al.
Published: (2022-10-01)

Temporal trend in risk of prostate cancer death in men with favourable-risk prostate cancer
by: Frederik F. Thomsen, et al.
Published: (2024-04-01)

Human intermediate prostate cancer stem cells contribute to the initiation and development of prostate adenocarcinoma
by: Jie Mu, et al.
Published: (2024-09-01)

The cell fates of intermediate cell population in prostate development
by: Xiaoyu Zhang, et al.
Published: (2024-08-01)

Navigating the evolving diagnostic and therapeutic landscape of low- and intermediate-risk prostate cancer
by: Fabio Zattoni, et al.
Published: (2024-10-01)

Intermediate risk prostate tumors contain lethal subtypes
by: William L. Harryman, et al.
Published: (2025-01-01)

Economic results of agricultural holdings in less favoured areas
by: F. Střeleček, et al.
Published: (2008-11-01)

Active surveillance should not be routinely considered in ISUP grade group 2 prostate cancer
by: Giorgio Gandaglia, et al.
Published: (2023-09-01)

The role of endogenous testosterone in relationship with low- and intermediate-risk prostate cancer: a systematic review
by: Antonio Benito Porcaro, et al.
Published: (2024-10-01)

Active surveillance of patients with low and intermediate risk prostate cancer
by: Ramilya D. Andreeva, et al.
Published: (2023-09-01)

Cost–Utility Analysis of Radiation Treatment Modalities for Intermediate-Risk Prostate Cancer
by: Najlaa Alyamani, et al.
Published: (2021-06-01)

Restoring grazing agroecosystems in Mediterranean less favoured areas for resilience and productivity: experts opinion
by: Ioanna Poulopoulou, et al.
Published: (2024-11-01)

The Axiological Approach to the Regulation of the Right to a Favourable Environment
by: Mikhail Permilovskiy
Published: (2012-10-01)

Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer
by: Benedikt Hoeh, et al.
Published: (2022-03-01)

The support of farming and revenues of enterprises located in less- favoured areas in Slovakia
by: Š. Buday
Published: (2002-09-01)

Hypofractionated versus conventional fractionation external beam radiotherapy in intermediate and high risk localized prostate cancer
by: Eileen Samuel, et al.
Published: (2024-02-01)

Identification of donor parents containing favourable alleles for improving target American cotton hybrid (NA 1325 × L 604)
by: BALAKRISHNA B, et al.
Published: (2023-03-01)

Influence of Biopsy Gleason Score on the Risk of Lymph Node Invasion in Patients With Intermediate-Risk Prostate Cancer Undergoing Radical Prostatectomy
by: Mike Wenzel, et al.
Published: (2021-12-01)

Direct comparison of low-dose-rate brachytherapy versus radical prostatectomy using the surgical definition of biochemical recurrence for patients with intermediate-risk prostate cancer
by: Hideyasu Tsumura, et al.
Published: (2022-04-01)

Analytical Validation of MyProstateScore 2.0—Active Surveillance: A Urinary-Based Clinical RT-PCR Prostate Cancer Assay
by: Tabea M. Setera, et al.
Published: (2026-05-01)

Southern Europe is becoming climatically favourable for African birds: anticipating the establishment of a new species
by: Sandro López-Ramírez, et al.
Published: (2023-05-01)

What is favourable conservation status?: A systematic map protocol
by: Alice M. Oswald, et al.
Published: (2025-02-01)

Land Use Favourability Assessment Based on Soil Characteristics and Anthropic Pollution. Case Study Somesul Mic Valley Corridor, Romania
by: Ioan Matei, et al.
Published: (2020-08-01)

SIMPROVING THE ECONOMIC ACTIVITIES IN THE LESS FAVOURED AREAS OF ROMANIA
by: Tileaga Cosmin, et al.
Published: (2011-07-01)

Effect of Glison index on survival of patients with localized prostate cancer in Samara region
by: R. D. Andreeva, et al.
Published: (2022-05-01)

The Evaluation of Radiolabeled Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography for Initial Staging in Intermediate-Risk Prostate Cancer Patients: A Retrospective Multicenter Analysis
by: Laura Evangelista, et al.
Published: (2024-12-01)

Selection of favourable targets for the in-situ conversion of continental oil shale in China
by: Pingchang Sun, et al.
Published: (2023-08-01)

Estimation of technical efficiency of Czech farms operating in less favoured areas
by: Tamara Rudinskaya, et al.
Published: (2019-10-01)

Multi-criteria assessment of less favoured areas: A state level
by: Karmen Pažek, et al.
Published: (2018-01-01)

Impact of androgen deprivation therapy in patients with unfavorable intermediate-risk prostate cancer receiving brachytherapy-based dose-escalated radiation therapy
by: Nikhil T. Sebastian, et al.
Published: (2024-09-01)

The Slow Demise Of The Most Favoured Nation
by: Frances Annmarie Duffy
Published: (2021-12-01)

Support of the use of agricultural land in less-favoured areas of the CR
by: M. Štolbová
Published: (2005-05-01)

Should localized prostate cancer in the favourable group no longer be treated?
by: Kamel Hamizi, et al.
Published: (2022-01-01)

Active surveillance in males with low- to intermediate-risk localized prostate cancer: A modern prospective cohort study
by: Arnas Rakauskas, et al.
Published: (2021-07-01)

Androgen deprivation therapy and radiotherapy in intermediate-risk prostate cancer: A systematic review and meta-analysis
by: Jiuzhou Chen, et al.
Published: (2023-01-01)